Neurogene shares owned by UBS Group
Historical chart of UBS Group investment in Neurogene
Tip: Access up to 7 years of quarterly data
All positions including Neurogene held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurogene by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $495k | 9.7k | 50.90 |
2023-12-31 | $19k | 1.0k | 19.38 |